Dutch Life Sciences Trend Analysis 2017

The Netherlands is a leader in the life sciences and biotech industry, ranked as No.4 worldwide for medical technology patent applications and No. 9 worldwide for biotechnology patent applications. More than 2,500 life sciences, medical technology companies and research organisations call the country home, and the region has attracted major multinational companies, including Johnson &…

UK Life Sciences Trend Analysis 2017

The UK is firmly established as a global centre for life sciences, with a strong history of innovation and entrepreneurship. Across the life science sector, almost half a million jobs are supported, with the activities of these companies directly contributing £14.5bn to the economy, and providing an additional £15.9bn indirectly. Pharmaceuticals dominate the sector, but…

Sumitomo Chemical reference: When are marketing authorisations valid?

By Dr Beatriz San Martín & Phil Bilney In the recent Sumitomo Chemical preliminary ruling which is of relevance not only to the chemical and agriculture industry but also to the pharmaceutical industry, the CJEU has held that a supplementary protection certificate (“SPC”) for a plant protection product (“PPP”) cannot be sought on the basis of an emergency…

Competition versus Patents – Anatomy of an underlying policy tension

By Bertold Bär-Bouyssière[1] 2013 has seen significant tensions between antitrust enforcement and patents. The various “pay for delay” cases are the most visible development, but there are many others. increasingly, competition authorities challenge the use of patents or virtually ignore them when applying competition law. What is the ideology behind these occurrences? The short article…

LIFE SCIENCES – WEEKLY INDUSTRY NEWS

Belarus Ambulance Doctors: Underpaid And Overworked, by Vadzim Smok, Posted on BelarusDigest Leading up to New Year’s Eve and throughout the first week of 2014, employees of the Minsk municipal ambulance service launched a protest. They are demanding a raise in salaries and improved labour conditions. The healthcare sector in Belarus remains financed by the state and has…

Patent Settlements as an endangered species

  Authors       James R.M. Killick   Partner   White & Case   Practice Experience   James Killick heads the Firm’s Global Pharmaceuticals and Healthcare practice. He is a litigator with a broad range of European law experience, advising clients on pharmaceuticals, competition, international trade (customs, export control, dumping) and State aid. He…